Oncology Medical News about colorectal tumors;MLH1- and MSH2-deficient

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers
Virchows Archiv, 07/03/08

Müller A et al. - In a trial to identify MLH1 or MSH2-deficient colorectal tumours, it was found that RT-PCR allows relative quantification of MMR gene mRNA expression in formalin-fixed and paraffin-embedded tissue, and this approach enables quantification of haploinsufficiency due to nonsense-mediated mRNA decay in normal tissue and B-lymphocytes from pts carrying MSH2 germline mutations and may be useful for identification of asymptomatic carriers of pathogenic germline mutations

Methods

Based on the principle of nonsense-mediated mRNA decay, MLH1 or MSH2-deficient colorectal tumours were identified through relative quantification of mRNA expression with real-time PCR (RT-PCR) analysis

Results

MLH1 and MSH2 mRNAs were almost equally expressed as defined by MLH1 to MSH2 transcript ratio in 16 microsatellite stable, mismatch repair (MMR) proficient tumours
A close correlation between loss of protein expression and MMR–mRNA levels was found in highly microsatellite instable (MSI-H) tumours deficient of MLH1 or MSH2
MLH1/MSH2 ratio was low in 11 sporadic and 9 hereditary MLH1-deficient carcinomas, whereas the ratio was high in 17 MSH2-deficient hereditary non-polyposis colorectal cancer (HNPCC) associated carcinomas
In the normal tissues of HNPCC pts with MSH2 mutations, the MLH1/MSH2 transcript ratios were significantly elevated as compared with the ratios of normal mucosa in pts with MMR-proficient tumours
Analysis of B-lymphocytes of HNPCC pts with proven MMR gene mutation confirmed these findings

<< Previous
Evidence of poorer survival in pregnancy-associated breast cancer

Next >>
Overexpression of Pokemon in non-small cell lung cancer and...